rs3739822

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_018249.6(CDK5RAP2):​c.5418C>T​(p.Pro1806Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0262 in 1,613,944 control chromosomes in the GnomAD database, including 658 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 60 hom., cov: 32)
Exomes 𝑓: 0.026 ( 598 hom. )

Consequence

CDK5RAP2
NM_018249.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.113

Publications

11 publications found
Variant links:
Genes affected
CDK5RAP2 (HGNC:18672): (CDK5 regulatory subunit associated protein 2) This gene encodes a regulator of CDK5 (cyclin-dependent kinase 5) activity. The protein encoded by this gene is localized to the centrosome and Golgi complex, interacts with CDK5R1 and pericentrin (PCNT), plays a role in centriole engagement and microtubule nucleation, and has been linked to primary microcephaly and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
CDK5RAP2 Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • microcephaly 3, primary, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • corpus callosum, agenesis of
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 9-120400775-G-A is Benign according to our data. Variant chr9-120400775-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.113 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0712 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK5RAP2NM_018249.6 linkc.5418C>T p.Pro1806Pro synonymous_variant Exon 35 of 38 ENST00000349780.9 NP_060719.4 Q96SN8-1B3KVI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK5RAP2ENST00000349780.9 linkc.5418C>T p.Pro1806Pro synonymous_variant Exon 35 of 38 1 NM_018249.6 ENSP00000343818.4 Q96SN8-1

Frequencies

GnomAD3 genomes
AF:
0.0254
AC:
3860
AN:
152114
Hom.:
59
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0225
Gnomad AMI
AF:
0.125
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.0417
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.0407
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0263
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.0239
AC:
6011
AN:
251370
AF XY:
0.0231
show subpopulations
Gnomad AFR exome
AF:
0.0231
Gnomad AMR exome
AF:
0.0128
Gnomad ASJ exome
AF:
0.0173
Gnomad EAS exome
AF:
0.0411
Gnomad FIN exome
AF:
0.0377
Gnomad NFE exome
AF:
0.0269
Gnomad OTH exome
AF:
0.0284
GnomAD4 exome
AF:
0.0262
AC:
38362
AN:
1461712
Hom.:
598
Cov.:
31
AF XY:
0.0256
AC XY:
18589
AN XY:
727150
show subpopulations
African (AFR)
AF:
0.0218
AC:
729
AN:
33472
American (AMR)
AF:
0.0128
AC:
571
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
451
AN:
26132
East Asian (EAS)
AF:
0.0734
AC:
2913
AN:
39700
South Asian (SAS)
AF:
0.00715
AC:
617
AN:
86248
European-Finnish (FIN)
AF:
0.0351
AC:
1872
AN:
53408
Middle Eastern (MID)
AF:
0.0399
AC:
226
AN:
5660
European-Non Finnish (NFE)
AF:
0.0265
AC:
29416
AN:
1111996
Other (OTH)
AF:
0.0260
AC:
1567
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1995
3991
5986
7982
9977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1126
2252
3378
4504
5630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0254
AC:
3865
AN:
152232
Hom.:
60
Cov.:
32
AF XY:
0.0259
AC XY:
1926
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0224
AC:
932
AN:
41534
American (AMR)
AF:
0.0156
AC:
239
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
65
AN:
3468
East Asian (EAS)
AF:
0.0417
AC:
216
AN:
5174
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4824
European-Finnish (FIN)
AF:
0.0407
AC:
432
AN:
10604
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0263
AC:
1788
AN:
68012
Other (OTH)
AF:
0.0208
AC:
44
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
190
381
571
762
952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0246
Hom.:
88
Bravo
AF:
0.0245
Asia WGS
AF:
0.0410
AC:
141
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 08, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary Microcephaly, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
4.5
DANN
Benign
0.38
PhyloP100
-0.11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3739822; hg19: chr9-123163053; API